###begin article-title 0
###xml 52 78 52 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 52 78 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 84 90 <span type="species:ncbi:10090">Murine</span>
The Role of Scavenger Receptor B1 in Infection with Mycobacterium tuberculosis in a Murine Model
###end article-title 0
###begin p 1
Conceived and designed the experiments: GS GDB. Performed the experiments: GS RG GM. Analyzed the data: GS GDB. Contributed reagents/materials/analysis tools: FB GDB. Wrote the paper: GS GDB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 24 50 24 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 24 50 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 52 55 <span type="species:ncbi:1773">Mtb</span>
###xml 185 188 <span type="species:ncbi:1773">Mtb</span>
The interaction between Mycobacterium tuberculosis (Mtb) and host cells is complex and far from being understood. The role of the different receptor(s) implicated in the recognition of Mtb in particular remains poorly defined, and those that have been found to have activity in vitro were subsequently shown to be redundant in vivo.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 828 831 828 831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 850 858 850 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 894 897 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1171 1174 1167 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 62 <span type="species:ncbi:1773">Mtb</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 939 942 <span type="species:ncbi:1773">Mtb</span>
###xml 952 957 <span type="species:ncbi:10090">mouse</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
###xml 1220 1223 <span type="species:ncbi:1773">Mtb</span>
###xml 1234 1239 <span type="species:ncbi:10090">mouse</span>
To identify novel receptors involved in the recognition of Mtb, we screened a macrophage cDNA library and identified scavenger receptor B class 1 (SR-B1) as a receptor for mycobacteria. SR-B1 has been well-described as a lipoprotein receptor which mediates both the selective uptake of cholesteryl esters and the efflux of cholesterol, and has also recently been implicated in the recognition of other pathogens. We show here that mycobacteria can bind directly to SR-B1 on transfected cells, and that this interaction could be inhibited in the presence of a specific antibody to SR-B1, serum or LDL. We define a variety of macrophage populations, including alveolar macrophages, that express this receptor, however, no differences in the recognition and response to mycobacteria were observed in macrophages isolated from SR-B1-/- or wild type mice in vitro. Moreover, when wild type and SR-B1-/- animals were infected with a low dose of Mtb (100 CFU/mouse) there were no alterations in survival, bacterial burdens, granuloma formation or cytokine production in the lung. However, significant reduction in the production of TNF, IFNgamma, and IL10 were observed in SR-B1-/- mice following infection with a high dose of Mtb (1000 CFU/mouse), which marginally affected the size of inflammatory foci but did not influence bacterial burdens. Deficiency of SR-B1 also had no effect on resistance to disease under conditions of varying dietary cholesterol. We did observe, however, that the presence of high levels of cholesterol in the diet significantly enhanced the bacterial burdens in the lung, but this was independent of SR-B1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
SR-B1 is involved in mycobacterial recognition, but this receptor plays only a minor role in anti-mycobacterial immunity in vivo. Like many other receptors for these pathogens, the loss of SR-B1 can be functionally compensated for under normal conditions.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 108 134 108 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 697 700 697 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schafer1">[1]</xref>
###xml 765 773 765 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 929 932 929 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Zimmerli1">[2]</xref>
###xml 933 936 933 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Reiling2">[7]</xref>
###xml 1113 1116 1113 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schafer2">[8]</xref>
###xml 108 134 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 136 139 <span type="species:ncbi:1773">Mtb</span>
###xml 248 251 <span type="species:ncbi:1773">Mtb</span>
###xml 400 403 <span type="species:ncbi:1773">Mtb</span>
###xml 474 477 <span type="species:ncbi:1773">Mtb</span>
###xml 1241 1244 <span type="species:ncbi:1773">Mtb</span>
Tuberculosis is the leading cause of death worldwide from a single infectious disease. The causative agent, Mycobacterium tuberculosis (Mtb), enters the host typically via aerosols, and alveolar macrophages are considered the first cells to engulf Mtb and become infected. Although the initial interaction of the pathogen with the host macrophage is considered a critical step in the pathogenesis of Mtb, the role of the receptors that play a role in mediating the entry of Mtb into macrophages and in transducing intracellular signals is very controversial and far from being understood. Over the years, more than a dozen receptors have been shown to recognize and bind mycobacteria (reviewed in [1]). However, the role of these receptors has been mostly based on in vitro examination in transfected cells; studies using inhibitors or animals deficient for specific receptors have indicated that these receptors are dispensable [2]-[7]. Since no direct functional-based search for the macrophage receptors involved in mycobacterial recognition has been performed, here we utilised a generalized screening method [8] with which we identified scavenger receptor B class 1 (SR-B1) as a novel macrophage receptor involved in the recognition of Mtb.
###end p 9
###begin p 10
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Peiser1">[9]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Zimmerli1">[2]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Neyrolles1">[10]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Bowdish1">[11]</xref>
###xml 259 262 <span type="species:ncbi:1773">Mtb</span>
Scavenger receptors belong to a family of cell surface transmembrane glycoproteins with broad ligand-binding abilities and important roles in atherogenesis, innate immunity and macrophage regulation (reviewed in [9]). Although their impact for recognition of Mtb has not been extensively studied, there are a few reports that show the general involvement of scavenger receptors in binding of mycobacteria [2], [10]. Recently, the scavenger receptors MARCO and SR-A were shown to be involved in binding of cord factor [11].
###end p 10
###begin p 11
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton1">[12]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Connelly1">[14]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Fidge1">[15]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton1">[12]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton2">[16]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Calvo1">[18]</xref>
###xml 1013 1023 1013 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1124 1125 1124 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1134 1135 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1146 1150 1146 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Philips1">[19]</xref>
###xml 1152 1156 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Vishnyakova1">[20]</xref>
###xml 1282 1286 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Philips1">[19]</xref>
###xml 1392 1396 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Voisset1">[21]</xref>
###xml 1398 1402 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Catanese1">[22]</xref>
###xml 1498 1502 1498 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Rodrigues1">[23]</xref>
###xml 976 981 <span type="species:ncbi:9606">human</span>
###xml 1013 1023 <span type="species:ncbi:7227">Drosophila</span>
###xml 1341 1358 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 1360 1363 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Scavenger receptor B1, in particular, has been well-described as a lipoprotein receptor which is expressed primarily in liver and nonplacental steroidogenic tissues, and mediates both the selective uptake of cholesteryl esters and the efflux of cholesterol [12]-[14]. A member of the CD36 family of scavenger receptors, SR-B1 consists of 509 amino acids and is expressed as a 82kDa glycoprotein with two cytoplasmic C- and N-terminal domains separated by a large extracellular domain [15]. This receptor has been shown to interact with both native and chemically modified (oxidized and acetylated) low-density lipoprotein (LDL), high-density lipoprotein (HDL), very-low-density lipoprotein and anionic phospholipids [12], [16]-[18]. Accumulating evidence suggests that the function of SR-B1 as well as other members of the CD36 family is not solely linked to cholesterol metabolism but involves a wide spectrum of activities, including microbial recognition. For example, the human homologue CLA-1 as well as the Drosophila homologue Pes have been shown to mediate binding and uptake of various bacteria, including both Gram+ and Gram- organisms [19], [20] with Pes being the only member of the CD36 family so far that has been described to be involved in mycobacterial recognition [19]. Furthermore, SR-B1 was shown to mediate the entry of hepatitis C virus (HCV) in an HDL-dependent manner [21], [22], while it also plays an important role in the infection of hepatocytes by the malaria parasite [23].
###end p 11
###begin p 12
###xml 119 127 119 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Here we have identified SR-B1 as a receptor for mycobacteria, and show that it can mediate the binding of mycobacteria in vitro. However, we found that SRBI plays only a minor role in vivo and that its function can be compensated for by other macrophage receptors.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Identification of SR-B1 as a Macrophage Receptor Involved in Binding of Mycobacteria
###end title 14
###begin p 15
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Brown1">[24]</xref>
###xml 264 283 264 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 801 808 801 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1A</xref>
###xml 1005 1012 1005 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1B</xref>
###xml 1100 1104 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Taylor1">[25]</xref>
###xml 1209 1222 1209 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1A and B</xref>
###xml 264 283 <span type="species:ncbi:1765">Mycobacterium bovis</span>
###xml 284 308 <span type="species:ncbi:33892">bacillus Calmette-Guerin</span>
###xml 663 669 <span type="species:ncbi:10090">murine</span>
To identify new receptors involved in binding and recognition of mycobacteria, a retroviral cDNA expression library, generated from RAW264.7 macrophages [24], was stably expressed in NIH3T3 cells and visually screened by fluorescent microscopy for binding of live Mycobacterium bovis bacillus Calmette-Guerin expressing Green Fluorescent Protein (BCG-GFP). Positive cells were isolated and enriched in culture until almost pure colonies of BCG-binding cells were obtained. After isolation of their genomic DNA and re-amplification of the stably inserted cDNA fragments originating from the RAW264.7 library, a 2.5kb cDNA fragment corresponding to the full-length murine scavenger receptor B class 1 (SR-B1) was obtained that was tested positive for BCG-GFP binding when re-inserted into NIH3T3 cells (Fig. 1A). When quantified for mycobacterial binding using luciferase expressing BCG cells (BCG-lux) the SR-B1 expressing NIH3T3 revealed a 7-fold increase in BCG binding compared to vector control cells (Fig. 1B). To include a positive control for BCG-binding, NIH3T3 cells stably expressing SIGNR1 [25] were used, and these cells showed slightly more mycobacterial binding of about 12-fold versus controls (Fig. 1A and B).
###end p 15
###begin title 16
Identification of SR-B1 as a receptor for mycobacteria.
###end title 16
###begin p 17
###xml 569 572 <span type="species:ncbi:10116">rat</span>
NIH3T3 cells stably transfected with empty vector pFBneo (negative control), SR-B1 or SIGNR1 (positive control), respectively, were incubated with BCG-GFP (A) or BCG-lux (B) and assessed for binding by fluorescence microscopy or luciferase activity, respectively. Shown is the x-fold increase of luciferase activity compared to vector control which was set as 1. Experiments were performed in triplicate and normalised to cell number by CFSE staining. (C) Western Blot showing expression of SR-B1 in various untransfected cell lines as indicated. Cellular lysates from rat liver were included as a control, and GAPDH served as loading control. (D) FACS analysis of R6F cells stably transduced with pFB (vector control), SR-B1 or SIGNR1, and stained with anti-SR-B1 or anti-SIGNRI, as indicated. (E) FACS assay showing binding/uptake of DiI-LDL to R6F cells stably expressing pFB (vector control), SR-B1 or SIGNR1. (F) Binding of FITC-labelled zymosan to R6F cells stably expressing pFB (vector control), SR-B1 or SIGNR1, as quantified by fluorometry. Shown is the x-fold increase of fluorescence compared to vector control which was set as 1. Experiments were performed in triplicate and normalised to cell number by CFSE staining.
###end p 17
###begin title 18
Characterization of Mycobacterial Binding to SR-B1 In Vitro Using Transfected Cells
###end title 18
###begin p 19
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1C</xref>
###xml 415 422 415 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1D</xref>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1E</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton2">[16]</xref>
###xml 593 600 593 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1F</xref>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Taylor1">[25]</xref>
To test BCG binding in cells which do not express any endogenous SR-B1, we screened several cell lines by Western blotting. Using this approach, we found that R6F cells were negative for SR-B1, while both NIH3T3 cells and RAW264.7 macrophages expressed this receptor (Fig. 1C). We therefore generated R6F cells stably expressing SR-B1 or SIGNR1 (as a positive control) and tested their receptor expression by FACS (Fig. 1D). These cells were also functionally tested for binding of known ligands for the respective receptors, including DiI-labeled LDL (Fig. 1E, [16]), for SR-B1, and zymosan (Fig. 1F, [25]), for SIGNRI.
###end p 19
###begin p 20
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2A</xref>
###xml 601 608 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2B</xref>
###xml 723 730 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2A</xref>
SR-B1 is a lipoprotein receptor, and we observed a significant decrease in the binding of BCG-lux to R6F cells expressing SR-B1 when binding was performed in the presence of serum (Fig. 2A, left panel). Notably, binding of mycobacteria to SR-B1 transfected cells, although reduced, still occurred in the presence of serum. To further investigate whether the serum-inhibition of bacterial binding was direct or indirect, we performed experiments where BCG-lux was pre-incubated in medium in the presence or absence of serum and then added to SR-B1 expressing cells in the presence or absence of serum (Fig. 2B, left panel). The bacteria pre-incubated in the absence of serum were inhibited by serum, as observed before (see Fig. 2A, left panel). A similar effect was observed when the bacteria were pre-incubated in the presence of serum; binding of these bacteria was only inhibited by the presence of serum during the binding assay. Importantly, pre-incubation of the bacteria in serum did not affect subsequent binding to the SR-B1 expressing cells in the absence of serum. Therefore the serum-inhibition effect was due to direct competition of serum components for the receptor rather than an "opsonization" effect on the bacteria. Based on this finding, all later experiments were performed in the absence of serum.
###end p 20
###begin title 21
###xml 28 31 <span type="species:ncbi:1773">Mtb</span>
Characterization of BCG and Mtb binding to SR-B1 transfected cells.
###end title 21
###begin p 22
###xml 111 114 <span type="species:ncbi:1773">Mtb</span>
###xml 584 587 <span type="species:ncbi:1773">Mtb</span>
###xml 1143 1146 <span type="species:ncbi:1773">Mtb</span>
###xml 1328 1331 <span type="species:ncbi:1773">Mtb</span>
R6F cells stably transfected with the indicated constructs were incubated with either BCG-lux (left panels) or Mtb-lux (right panels), and quantified for binding by measuring luciferase activity. Experiments were performed in triplicate and normalised to cell number by CFSE staining. (A) Quantification of mycobacterial binding to SR-B1 expressing cells (white bars) or vector control cells (black bars) in the presence or absence of serum, as indicated. Shown is the x-fold increase of luciferase activity compared to vector control which was set as 1. (B) Mycobacteria (BCG-lux or Mtb-lux) were pre-incubated in medium with or without 10% serum, prior binding to R6F-SR-B1 cells also in the presence or absence of 10% serum. Shown is % of luciferase activity relative to binding to R6F-SR-B1 cells in the absence of serum, which was set at 100%. (C) Effect of LDL on binding of mycobacteria to R6F cells expressing SR-B1 or SIGNR1, as indicated. Shown is % of luciferase activity relative to R6F-SR-B1 or R6F-SIGNR1 cells, respectively, in the absence of additives. (D) Effect of BAL fluid and serum (as a control) on binding of BCG-lux or Mtb-lux to SR-B1 expressing R6F cells. Shown is % of luciferase activity relative to R6F-SR-B1 in the absence of additives. (E) Effect of anti-SR-B1 antibodies on binding of BCG-lux or Mtb-lux to SR-B1 or SIGNR1 transfected R6F cells. The white bars show % of luciferase activity relative to binding in the absence of antibody (black bars). (F) SR-B1 expressing R6F cells were incubated with mycobacteria in the presence of increasing concentrations of MbetaCD. Binding of BCG-lux is shown as % of luciferase activity relative to control (no MbetaCD).
###end p 22
###begin p 23
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Fidge1">[15]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton2">[16]</xref>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2C</xref>
###xml 700 707 700 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2D</xref>
To further demonstrate this competition, we performed binding experiments in the presence of LDL in serum-free medium. Although SR-B1 is known to have broad ligand specificity [15], and recognizes various different lipoprotein classes, we chose unmodified LDL as this particle has shown to bind specifically to SR-B1 but not CD36 or class A scavenger receptors [16]. As shown in Fig. 2C (left panel), both LDL and serum significantly blocked binding of BCG-lux to SR-B1 expressing R6F cells, while this effect was not observed in R6F cells expressing SIGNR1. We also observed that bronchoalveolar lavage containing lung surfactant significantly blocked binding of BCG-lux to SR-B1 transfected cells (Fig. 2D).
###end p 23
###begin p 24
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Gatfield1">[26]</xref>
###xml 566 573 566 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2E</xref>
###xml 991 998 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2F</xref>
As mentioned above, SR-B1 is well characterised regarding its role in cholesterol metabolism. Also, it is known that mycobacteria can bind to free cholesterol in the membrane [26]. Therefore experiments were designed to investigate whether the observed binding of BCG-lux to cells expressing SR-B1 was due to direct interaction of the bacteria with the receptor, or because of an increased accumulation of cholesterol in the membrane. To this end, the binding of BCG-lux to SR-B1 was investigated after blocking of the receptor with a specific antibody. As shown in Fig. 2E (left panel) SR-B1 expressing R6F cells pre-incubated with anti-SR-B1 showed a significant reduction in binding of BCG-lux, whereas the antibody had no affect on the binding of the mycobacteria to control SIGNR1 cells. This was further supported by the observation that depletion of the membrane's cholesterol by cyclodextrins did not significantly reduce the amount of BCG-lux binding to R6F cells expressing SR-B1 (Fig. 2F), although SR-B1 transfected R6F cells did show more cholesterol accumulation when stained with filipin compared to control cells (data not shown).
###end p 24
###begin p 25
###xml 73 99 73 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 299 308 299 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2A&#8211;E</xref>
###xml 458 474 458 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2A, C and D</xref>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2B</xref>
###xml 691 698 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2E</xref>
###xml 73 105 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 294 297 <span type="species:ncbi:1773">Mtb</span>
###xml 338 341 <span type="species:ncbi:1773">Mtb</span>
###xml 592 595 <span type="species:ncbi:1773">Mtb</span>
We next wanted to test whether these results also held true for virulent Mycobacterium tuberculosis H37Rv. Although we had some difficulty in generating uniform suspensions of this bacterium which interfered with our binding assays, all the trends observed with BCG-lux could be confirmed with Mtb (Fig. 2A-E; right panels). Importantly, Mtb-lux bound to SR-B1 transfected R6F cells and this binding could be inhibited by the presence of serum, LDL and BAL (Fig. 2A, C and D, right panels), which was due to direct competition for the receptor (Fig. 2B, right panel). Further, the binding of Mtb-lux to SR-B1 expressing cells could be inhibited in the presence of an antibody against SR-B1 (Fig. 2E, right panel). Thus overall, these data suggest that SR-B1 can directly recognize mycobacteria and that this interaction can be inhibited by serum and surfactant components.
###end p 25
###begin title 26
The Role of SR-B1 for Mycobacterial Infection of Primary Cells
###end title 26
###begin p 27
###xml 448 455 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3A</xref>
###xml 605 608 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 752 759 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3B</xref>
###xml 873 876 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Stokes1">[27]</xref>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
Having demonstrated that SR-B1 can mediate the recognition of mycobacteria in transfected cells, we next investigated the contribution of this receptor on primary cells. Initially, different macrophage populations (alveolar macrophages, bone-marrow derived macrophages (BMDmO), resident as well as thioglycollate-elicited peritoneal macrophages) were isolated from wild type C57BL/6 mice and tested for the expression of SR-B1 by Western Blotting (Fig. 3A). This analysis demonstrated the expression of this receptor on all macrophage populations examined, and was absent in macrophages derived from SR-B1-/- mice. Importantly, alveolar macrophages and BMDmO expressed highly SR-B1, therefore these cell populations were tested for binding of BCG-lux (Fig. 3B). Surprisinlgy, no statistically significant differences in binding could be observed between wild type and SR-B1-/- macrophages in the absence of serum. Notably, mycobacterial binding to resident alveolar macrophages was inefficient when compared to BMDmO, as has been demonstrated in a previous study [27].
###end p 27
###begin title 28
The role of SR-B1 in mycobacterial recognition in primary cells.
###end title 28
###begin p 29
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 797 800 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
(A) Western Blot assessing expression of SR-B1 in different macrophage populations derived from wild type C57/BL6 and SR-B1-/- mice, as indicated. (B) Alveolar macrophages and BMDmO isolated from wild type (black bars) and SR-B1-/- mice (white bars) were tested for BCG-lux binding in the absence of serum. Shown is the relative luciferase activity (R.L.U.), normalised to cell number by CFSE staining. (C) TNF production at 4 hr or 24 hr after binding of BCG-lux to alveolar macrophages or BMDmO isolated from wild type (black bars) and SR-B1-/- mice (white bars). Shown is x-fold increase in TNF production relative to control (no BCG binding). Experiments were normalised to cell number by CFSE staining. (D) Survival of BCG-lux in infected BMDmO isolated from wild type (solid lines) and SR-B1-/- mice (dashed lines). After infection of macrophages, unbound mycobacteria were removed and samples taken after the indicated time points to assess luciferase activity. Experiments were performed in triplicate, normalised to cell number by CFSE staining and shown as R.L.U. relative to time point 1.
###end p 29
###begin p 30
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3C</xref>
###xml 550 553 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 757 760 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1206 1209 1203 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1336 1343 1333 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3D</xref>
###xml 1369 1372 1366 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1610 1618 1607 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
When analysed for TNF production 4 hr or 24 hr after mycobacterial binding, no differences between wild type and SR-B1-/- macrophages were detected (Fig. 3C). Although the level of TNF was equally low after 4 hr in both macrophage populations, it increased considerably in BMDmO after 24 hr, presumably reflecting the differences in bacterial binding as described above. These experiments were repeated with varying parameters in bacterial binding, including different incubation times and temperatures, but no differences between wild type and SR-B1-/- macrophages were detected under any of the conditions tested (data not shown). We also found that the presence of serum inhibited binding of mycobacteria to BMDmO equally well in both wild type and SR-B1-/- macrophages, while the addition of MbetaCD (to deplete cholesterol membrane) had no effect on binding (data not shown). Furthermore, when we blocked SR-B1 with a specific antibody, binding of mycobacteria to the macrophages was unaltered compared to untreated controls (data not shown). Finally we investigated whether the survival of mycobacteria in macrophages was affected by the presence or absence of SR-B1. To this end, wild type and SR-B1-/- BMDmO were infected with BCG-lux and mycobacterial viability analysed over time by measuring luciferase activity. As shown in Fig. 3D, both wild type and SR-B1-/- macrophages could equally efficiently kill mycobacteria within the first 24 hr after infection, following which the bacteria started to replicate. Thus loss of SR-B1 has minimal impact on mycobacterial recognition by primary macrophages in vitro.
###end p 30
###begin title 31
###xml 40 66 40 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 40 66 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
SR-B1 Is Dispensable for Infection with Mycobacterium tuberculosis In Vivo
###end title 31
###begin p 32
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 110 136 110 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4A</xref>
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 471 478 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4B</xref>
###xml 529 532 529 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 642 649 642 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4B</xref>
###xml 747 754 747 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4C</xref>
###xml 762 765 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 881 888 881 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4D</xref>
###xml 944 951 940 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4E</xref>
###xml 994 997 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 110 142 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
To explore a potential role for SR-B1 in vivo, wild type and SR-B1-/- mice were aerosol infected with 100 CFU Mycobacterium tuberculosis H37Rv, and the development of disease monitored after 2 and 4 months. As shown in Fig. 4A, both wild type and SR-B1-/- mice survived and gained weight throughout the course of the infection. The lungs of both groups displayed inflammatory foci, consisting of patchy infiltrates of inflammatory cells, predominantly foamy macrophages (Fig. 4B). Typical granulomas were not observed. Some SR-B1-/- mice showed evidence of clefts of accumulated cholesterol, which were not observed in the wild type animals (Fig. 4B and data not shown). When the sizes of inflammatory foci were measured by morphometric analysis (Fig. 4C), SR-B1-/- mice did not show significant differences to the wild type mice. Furthermore, no differences in bacterial burdens (Fig. 4D) or production of TNF, IFNgamma, IL10, IL12p70 or IL6 (Fig. 4E) were detected between wild type and SR-B1-/- mice.
###end p 32
###begin title 33
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 60 63 <span type="species:ncbi:1773">Mtb</span>
The role of SR-B1 in vivo following low dose infection with Mtb.
###end title 33
###begin p 34
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 63 89 63 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1010 1013 1006 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 63 95 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
Wild type C57/BL6 and SR-B1-/- mice were infected with 100 CFU Mycobacterium tuberculosis H37Rv by aerosol route and sacrificed after 2 and 4 months. (A) Body weight was monitored throughout the course of the experiment and is presented as % of original body weight (time of infection) with the SEM shown as solid lines for wild type animals and dashed lines for SR-B1-/- mice. Lungs of infected animals were analysed at 2 and 4 months for histopathology by H&E staining (B). Also shown is a lung section showing the presence of clefts of accumulated cholesterol that were observed in some inflammatory foci in infected SR-B1-/- mice. Lung sections after 4 months of infection were further anlaysed by morphometric analysis to calculate the sizes of the inflammatory lesions (C). Lung homogenates were analysed at 2 and 4 months for bacterial burden (D), as well as the production of TNF, IFNgamma, IL10, IL12p70 and IL6 (E) with the black circles representing wild type and the open circles representing SR-B1-/- animals. Shown are the data from individual mice and the median value.
###end p 34
###begin p 35
###xml 88 94 88 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5</xref>
###xml 218 225 218 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5A</xref>
###xml 313 316 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 326 333 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5C</xref>
###xml 398 405 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5B</xref>
###xml 543 550 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5D</xref>
###xml 618 621 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 683 690 679 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5E</xref>
###xml 60 63 <span type="species:ncbi:1773">Mtb</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
We also tested the effects of infection with a high dose of Mtb, i.e 1000 CFU per lung (Fig. 5). As before, both groups of mice gained weight and did not display any adverse effects during the course of the infection (Fig. 5A). Although we detected significantly less pulmonary TNF, IL10 and IFNgamma in the SR-B1-/- animals (Fig. 5C), this did not correlate with differences in bacterial burdens (Fig. 5B). Although the inflammatory pathology was similar between both groups of mice, except for the presence of occasional cholesterol clefts (Fig. 5D and data not shown), the size of the inflammatory foci in the SR-B1-/- mice were found to be slightly increased (p-value of 0.032) (Fig. 5E).
###end p 35
###begin title 36
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 61 64 <span type="species:ncbi:1773">Mtb</span>
The role of SR-B1 in vivo following high dose infection with Mtb.
###end title 36
###begin p 37
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 90 64 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 619 622 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 64 96 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Wild type C57/BL6 and SR-B1-/- mice were infected with 1000 CFU Mycobacterium tuberculosis H37Rv by aerosol route and sacrificed after 4 months. (A) Body weight was monitored throughout the course of the experiment and is presented as % of original body weight (time of infection) with the SEM shown as solid lines for wild type animals and dashed lines for SR-B1-/- mice. Lungs of infected animals were analysed for bacterial burden (B), TNF, IFNgamma, IL10, IL12p70 and IL6 (C), histopathology (D) and inflammatory lesion size (E), with the black circles representing wild type and the open circles representing SR-B1-/- animals. Shown are the data from individual mice and the median value. *, p<0.05.
###end p 37
###begin p 38
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Martens1">[28]</xref>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 702 709 702 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6A</xref>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4A</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">5A</xref>
###xml 869 876 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6B</xref>
###xml 1051 1054 1051 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1096 1103 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6C</xref>
###xml 1118 1125 1118 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6A</xref>
###xml 1290 1293 1290 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1368 1375 1368 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6E</xref>
###xml 1458 1461 1458 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1483 1490 1483 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6E</xref>
###xml 1684 1687 1684 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1695 1702 1695 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6D</xref>
###xml 1745 1752 1745 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6F</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 452 455 <span type="species:ncbi:1773">Mtb</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 990 995 <span type="species:ncbi:10090">mouse</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1294 1298 <span type="species:ncbi:10090">mice</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
###xml 1544 1548 <span type="species:ncbi:10090">mice</span>
Elevated serum cholesterol levels are known to correlate with susceptibility to tuberculosis [28], and as SR-B1 is involved in cholesterol metabolism, we assessed the influence of cholesterol in the diet on susceptibility to mycobacterial infection in wild type and SR-B1-/- mice. Appropriate numbers of animals were fed either a low cholesterol (LC, 0.15% cholesterol) or a high cholesterol (HC, 1.25% cholesterol) diet and then infected with 100 CFU Mtb. Cholesterol levels at the time of infection were significantly higher in SR-B1-/- mice compared to wild type mice on either diet, and higher levels of cholesterol were detected in SR-B1-/- mice on the HC diet compared to animals on the LC diet (Fig. 6A). As observed in our previous experiments (Fig. 4A and 5A), all animals gained weight and did not show any adverse effects during the course of the infection (Fig. 6B). When the experiment was terminated after 4 months, there were similar relative differences between the various mouse strains in serum cholesterol levels, although the SR-B1-/- mice showed an overall general increase (Fig. 6C, compare with Fig. 6A). We also observed a slight, but significant, diet-dependent difference in bacterial burden of the lungs, with elevated bacterial levels in both wild type and SR-B1-/- mice on the HC diet compared to the corresponding animals on the LC diet (Fig. 6E). However, there was no difference in bacterial burden between wild type and SR-B1-/- mice on either diet (Fig. 6E). Despite the slightly elevated bacterial burdens in mice on HC diets, there were no significant differences in histopathology, except for the occasional presence of cholesterol clefts in SR-B1-/- lungs (Fig. 6D), or in the levels of pulmonary cytokine (Fig. 6F).
###end p 38
###begin title 39
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 50 53 <span type="species:ncbi:1773">Mtb</span>
The effect of cholesterol in SR-B1-/- mice during Mtb infection.
###end title 39
###begin p 40
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 199 225 199 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 830 833 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 199 231 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
Wild type C57/BL6 and SR-B1-/- mice were fed either a low cholesterol diet (LC, 0.15% cholesterol) or a high cholesterol diet (HC, 1.25% cholesterol) throughout the experiment, infected with 100 CFU Mycobacterium tuberculosis H37Rv by aerosol route and sacrificed after 4 months. (A) Levels of serum cholesterol following 2 weeks on the various diets, as indicated, prior to infection (black bars representing wild type, and white bars the SR-B1-/- animals). (B) Average mouse weight throughout the course of the experiment, presented as % of original body weight +/-SEM. 4 months after infection the mice were analyzed for serum cholesterol (C), histopathology (D), bacterial burdens (E), and pulmonary TNF, IFNgamma, IL10, IL12p70 and IL6 (F) with the black circles representing wild type and the open circles representing SR-B1-/- animals. Shown are the data from individual mice and the median value. *, p<0.05.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 383 396 383 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g001">Fig. 1A and B</xref>
###xml 673 683 673 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Philips1">[19]</xref>
###xml 72 75 <span type="species:ncbi:1773">Mtb</span>
###xml 203 206 <span type="species:ncbi:1773">Mtb</span>
###xml 311 317 <span type="species:ncbi:10090">murine</span>
###xml 673 683 <span type="species:ncbi:7227">Drosophila</span>
The identification of host pattern recognition receptors that recognise Mtb represents a potential opportunity for anti-mycobacterial prophylaxis, as the interruption of binding may functionally disrupt Mtb entry into its host cell niche. By screening a retroviral cDNA expression library derived from RAW264.7 murine macrophages, we identified SR-B1 as a receptor for mycobacteria (Fig. 1A and B). As a member of the CD36 family of scavenger receptors, which have been well described for their function in cholesterol metabolism, we show here that SR-B1 is also involved in mycobacterial recognition. To our knowledge, this activity so far has only been attributed to the Drosophila homologue Pes [19].
###end p 42
###begin p 43
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Acton1">[12]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Connelly1">[14]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Gatfield1">[26]</xref>
###xml 472 479 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2F</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-KellnerWeibel1">[29]</xref>
###xml 822 831 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2A&#8211;E</xref>
As SR-B1 is involved in cholesterol transport across the membrane [12]-[14] and as mycobacteria have been shown to display high binding capacity for free cholesterol [26], we wondered if the expression of SR-B1 would lead to an accumulation of cholesterol in the membrane and indirectly lead to increased mycobacterial binding. However, depletion of the membrane's cholesterol by cyclodextrins did not significantly reduce mycobacterial binding to SR-B1 expressing cells (Fig. 2F). This is supported by an earlier study on SR-B1 expression of transfected COS-7 cells, where the presence of SR-B1 had no effect on the level of free cholesterol [29]. We also demonstrated that mycobacteria bound directly to SR-B1, and that this binding could be competitively inhibited by specific antibodies, lipids, serum and surfactant (Fig. 2A-E).
###end p 43
###begin p 44
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3A</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Baranova1">[30]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Vishnyakova1">[20]</xref>
###xml 392 397 <span type="species:ncbi:9606">human</span>
While we clearly show that SR-B1 is involved in recognition of mycobacteria on transfected cells we could not define a role for this receptor in primary cells, although SR-B1 was clearly expressed in wild type macrophages (Fig. 3A) as has been shown earlier for the macrophage cell line RAW264.7 [30]. While disappointing, this was not entirely unexpected, as another study investigating the human homologue of SR-B1, was shown to recognise Gram positive and Gram negative bacteria in transfected, but not in primary cells [20].
###end p 44
###begin p 45
###xml 148 161 148 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3B and C</xref>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g003">Fig. 3B</xref>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Bowdish1">[11]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Randhawa1">[31]</xref>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Randhawa1">[31]</xref>
###xml 806 810 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Gatfield1">[26]</xref>
Studies on primary macrophages revealed no difference in binding of mycobacteria and subsequent TNF production in the presence or absence of SR-B1 (Fig. 3B and C). However, binding of mycobacteria to both wild type and SR-B1-/- BMDmO was much stronger than to alveolar macrophages (Fig. 3B), and this is likely to be due to the expression of other recognition receptors on these cells, as has been shown previously [11], [31]. We also found that serum blocked binding of mycobacteria to both wild type and SR-B1-/- alveolar macrophages and BMDmO (data not shown) as opposed to an earlier observation where serum components increased binding to BMDmO [31]. Furthermore, depletion of the membrane's cholesterol with MbetaCD had no effect on binding (data not shown), which is in contrast to a previous study [26]. This can be due to different macrophage populations, preparation techniques and different sera used. Also, other macrophage receptors might be more important for mycobacterial binding which render the role of the cholesterol content in the membrane redundant.
###end p 45
###begin p 46
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4D</xref>
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5B</xref>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6E</xref>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g004">Fig. 4B</xref>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 733 736 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 776 783 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5C</xref>
###xml 850 857 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5B</xref>
###xml 946 949 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1294 1301 1282 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g005">Fig. 5E</xref>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 195 198 <span type="species:ncbi:1773">Mtb</span>
###xml 427 430 <span type="species:ncbi:1773">Mtb</span>
###xml 528 533 <span type="species:ncbi:10090">mouse</span>
###xml 771 774 <span type="species:ncbi:1773">Mtb</span>
###xml 1289 1292 <span type="species:ncbi:1773">Mtb</span>
Our in vivo studies on the role of SR-B1 during mycobacterial infection also revealed no substantial difference between wild type and SR-B1-/- mice when infected with either a low or a high dose Mtb or when investigated in the context of dietary cholesterol (Fig. 4D, Fig. 5B, Fig. 6E). However, we did observe some clefts of accumulated cholesterol, limited largely to the peripheral parenchyma, in the absence of SR-B1 after Mtb infection (Fig. 4B). The accumulation of cholesterol in the inflammatory lesions of the SR-B1-/- mouse lungs might account for the fact that cholesterol transport across the macrophage membrane is impaired in these animals. Although we did detect decreased levels of TNF, IFNgamma and IL10 in the SR-B1-/- animals infected with a high dose Mtb (Fig. 5C), the bacterial burdens in both groups of animals was comparable (Fig. 5B). In fact, there were still substantial amounts of TNF and IFNgamma present in the SR-B1-/- lungs: 76% TNF and 63% IFNgamma levels compared to those found in wild type animals, while the amount of IL10 was decreased to 40% compared to wild type. While the changes in cytokine levels are likely to have contributed to the slight difference in size of the inflammatory lesions that were observed following infection with a high dose Mtb (Fig. 5E), we do not feel these data represent a significant biological difference between wild type and knockout animals.
###end p 46
###begin p 47
###xml 136 139 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 146 159 146 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6A and C</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Martens1">[28]</xref>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 623 630 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6E</xref>
###xml 748 762 748 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g006">Fig. 6C and 6E</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-VanderGeize1">[32]</xref>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 332 335 <span type="species:ncbi:1773">Mtb</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 920 923 <span type="species:ncbi:1773">Mtb</span>
The lack of a substantial effect of SR-B1 deficiency was surprising, however, considering the elevated serum cholesterol levels in SR-B1-/- mice (Fig. 6A and C). Indeed, a recent report demonstrated that high serum cholesterol levels in apolipoprotein E (ApoE) deficient mice fed on a HC diet, resulted in high susceptibility of to Mtb [28], although ApoE appeared to have a more pronounced influence on the regulation of plasma cholesterol than SR-B1. However, there were significantly increased bacterial numbers in the lungs of infected wild type and SR-B1-/- animals fed on the HC diet compared to mice on the LC diet (Fig. 6E), which was independent of SR-B1, and, interestingly, did not appear to correlate with the serum cholesterol levels (Fig. 6C and 6E). Although not detectable in the serum, animals fed the HC diet might still have elevated intracellular cholesterol stores which can be taken up and used by Mtb as a source of energy to their growth advantage [32]. This might explain why those animals on the HC diet displayed higher bacterial burdens in the lungs compared to those fed a LC diet. However, the role of SR-B1 for mycobacterial growth seems to be minor and independent of the diet.
###end p 47
###begin p 48
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schafer1">[1]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Pieters1">[33]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schlesinger1">[34]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Bulut1">[35]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Yadav1">[36]</xref>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 669 677 669 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-LeCabec1">[37]</xref>
###xml 733 740 733 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 740 743 740 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Hu1">[4]</xref>
###xml 831 839 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Jo1">[38]</xref>
###xml 905 908 905 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Holscher1">[5]</xref>
###xml 910 913 910 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Reiling1">[6]</xref>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Feng1">[39]</xref>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Drennan1">[40]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Abel1">[41]</xref>
###xml 1212 1219 1212 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 974 977 <span type="species:ncbi:1773">Mtb</span>
###xml 1121 1124 <span type="species:ncbi:1773">Mtb</span>
###xml 1194 1197 <span type="species:ncbi:1773">Mtb</span>
While playing a role for recognition of mycobacteria in an isolated context using transfected cells, our data supports the notion that macrophage receptors show redundancy when investigated in primary cells [1], [33]. This is true, for example, with the mannose receptor (MR), which has long been considered to play a central role in mycobacterial phagocytosis [34], and for the TLRs, which have recently emerged to contribute to the innate recognition of these pathogens [35], [36]. The situation is even more complex in vivo. Receptors such as CR3, for example, which is able to mediate both complement-opsonized as well as non-opsonized phagocytosis of mycobacteria in vitro on transfected cells [37] was not found to play a role in vivo[4]. Similarly contradicting findings have been described for the TLRs: although important in vitro[38], TLR2, TLR4, or mice triply deficient in TLR2, TLR4 and TLR9 [5], [6], [39] were infected with mycobacteria, no susceptibility to Mtb was observed. However, these data were contradicted by other groups showing that TLR2 and TLR4 do play roles in controlling the infection with Mtb [40], [41]. This clearly shows that when studying the interaction of Mtb with its host in vivo the particular experimental setting greatly affects the outcome.
###end p 48
###begin p 49
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Stokes2">[42]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-HallStoodley1">[43]</xref>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1192 1196 1192 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Bowdish1">[11]</xref>
###xml 1198 1202 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Stokes1">[27]</xref>
###xml 1605 1612 1605 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
###xml 1135 1140 <span type="species:ncbi:9606">human</span>
###xml 1145 1151 <span type="species:ncbi:10090">murine</span>
###xml 1255 1258 <span type="species:ncbi:1773">Mtb</span>
###xml 1382 1388 <span type="species:ncbi:10090">murine</span>
###xml 1548 1551 <span type="species:ncbi:1773">Mtb</span>
In this context, the preparation of the mycobacteria has much influence on the experimental observations: we and others found that mycobacteria bind to and activate macrophages to a much greater extent when sonicated rather than syringed ([42] and data not shown). Also, when performing the binding assay under shear conditions rather than static binding one would simulate the dynamic and physiological conditions in the lung much better and select for higher-affinity receptors [43]. With the static binding conditions as presented here, one would also identify low-affinity receptors. It is possible that SR-B1, being a true scavenger with broad ligand specificity, is a low-affinity receptor for mycobacteria and simply plays only a minor role in vivo. Experimental differences will also occur when different strains of mycobacteria (virulent vs. avirulent) and/or genetic background of the receptor-deficient mice (relatively resistant such as C57BL/6 vs. relatively susceptible such as BALB/c) are being used. To add to the complexity, different macrophage populations (i.e. resident vs. elicited vs. immune-activated as well as human vs. murine) express a different array of receptors [11], [27] and therefore respond differently to infection with Mtb. This is also important in our experimental approach: we identified SR-B1 when screening a cDNA library generated from the murine macrophage cell line RAW264.7. These cells might express a completely different array of receptors compared to primary cells, leading to the identification of Mtb-binding surface molecules that might not be relevant in vivo.
###end p 49
###begin p 50
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schafer1">[1]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Pieters1">[33]</xref>
###xml 53 56 <span type="species:ncbi:1773">Mtb</span>
###xml 158 161 <span type="species:ncbi:1773">Mtb</span>
As discussed in the literature before, it seems that Mtb enters the host cell via a number of possible receptor/ligand interactions [1], [33]. The ability of Mtb to engage multiple receptors (or receptor clusters) simultaneously might be an evolutionary advantage for its pathogenesis: in the absence of a single receptor, phagocyte infection by mycobacteria can be efficiently supported by alternative receptors.
###end p 50
###begin p 51
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 418 425 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008448-g002">Fig. 2D</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Ferguson1">[44]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Ferguson2">[45]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Baranova1">[30]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Sanchez1">[46]</xref>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Stokes1">[27]</xref>
###xml 465 468 <span type="species:ncbi:1773">Mtb</span>
###xml 834 839 <span type="species:ncbi:9606">human</span>
###xml 910 918 <span type="species:ncbi:9606">patients</span>
Taken together, we demonstrate that SR-B1 is another example of the diverse spectrum of receptors that recognize mycobacteria in vitro but is redundant in the extremely complex macrophage-mycobacterium interaction in vivo. On the one hand, this redundancy of SR-B1 in mycobacterial infection might be a result, at least in part, of surfactant blocking the bacterial-receptor interactions, as we demonstrated in vitro (Fig. 2D). Surfactant may directly compete with Mtb for the receptor binding site, or that aggregated mycobacteria alter their interaction with the host cells, as shown for SP-D [44], [45]. On the other hand, the redundancy may stem from down-regulation of this receptor during mycobacterial infection, as macrophage activation has been shown to suppress SR-B1 expression [30]. Furthermore, expression of the related human scavenger receptor CD36 has been found to be lower on monocytes in TB patients, and reverse to normal levels upon anti-mycobacterial treatment [46]. At the same time, when resident alveolar macrophages differentiate by cytokine stimulation, they increase the expression of surface receptors and show a higher affinity to bind mycobacteria [27], therefore maybe completely render any role of SR-B1 redundant.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Cell Culture
###end title 53
###begin p 54
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Freeman1">[47]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Morita1">[48]</xref>
###xml 366 367 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 7 13 <span type="species:ncbi:10090">murine</span>
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 80 83 <span type="species:ncbi:10116">rat</span>
###xml 227 231 <span type="species:ncbi:9913">calf</span>
NIH3T3 murine embryonic fibroblasts (ATCC), RAW264.7 murine macrophages (ATCC), rat 6 fibroblasts (R6F, [47]) and the packaging cell line plat-E [48] were grown in DMEM (Invitrogen) supplemented with 10% heat-inactivated fetal calf serum (Delta Bioproducts), 2mM L-glutamine, 100U/ml penicillin and 100microg/ml streptomycin (Sigma) in a humidified atmosphere (5% CO2) at 37degreesC, if not otherwise indicated.
###end p 54
###begin title 55
Ligand Binding Assays
###end title 55
###begin p 56
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 201 220 201 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 350 376 350 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Snewin1">[49]</xref>
###xml 776 777 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 887 888 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 201 220 <span type="species:ncbi:1765">Mycobacterium bovis</span>
###xml 350 382 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 421 424 <span type="species:ncbi:1773">Mtb</span>
###xml 817 820 <span type="species:ncbi:1773">Mtb</span>
###xml 1296 1302 <span type="species:ncbi:9986">rabbit</span>
###xml 1308 1313 <span type="species:ncbi:10090">mouse</span>
The cells used for the binding assays were plated in 24-well-plates at a density of 5x104 cells per well and allowed to adhere overnight. Nonopsonic binding studies were performed with live strains of Mycobacterium bovis bacilli Calmette-Guerin (BCG) expressing either Green Fluorescent Protein (BCG-GFP) or bacterial luciferase (BCG-lux) as well as Mycobacterium tuberculosis H37Rv expressing bacterial luciferase [49] (Mtb-lux) and FITC-labeled zymosan (Molecular Probes). Mycobacteria were grown in Middlebrook 7H9 (Difco) with 10% OADC (oleic acid, albumin, dextrose, catalase) enrichment in the presence of 10microg/ml kanamycin (BCG-GFP) or 50microg/ml hygromycin (BCG-lux), respectively, and kept as 15% glycerol stocks at -80degreesC at a density of approximately 5x106 particles. For binding studies, BCG or Mtb aliquots were thawed, spun in a microcentrifuge for 1 min at 13000g, washed twice in DMEM followed by vigorous vortexing, and aggregates were dispersed by sonication for 30 sec at 50W in a cuphorn sonicator. To infect cells, culture medium was removed, and mycobacterial suspension in serum-free DMEM (if not otherwise indicated) was added at a particle:cell ratio of 10:1. Where indicated, binding was performed in the presence of additives such as 10% serum, 1:100 diluted rabbit anti-mouse SR-B1 polyclonal antibody (NB 400-134, Novus Biologicals), 100microg/ml LDL, 50% bronchoalveolar lavage fluid (BAL), or methyl-beta-cyclodextrin (MbetaCD, Sigma), respectively, at the indicated concentrations. FITC-labeled zymosan was prepared similarly, sonicated for 3 min at 150W and added to the indicated cells at a particle:cell ratio of 10:1. The cells were then incubated with their ligands for 1 hr at 37degreesC, washed three times with DMEM and prepared for further analysis.
###end p 56
###begin title 57
Quantification of BCG- and Zymosan Binding
###end title 57
###begin p 58
Binding of BCG-lux to the cells was determined by lysis of the cells in 150microl 0.1% triton X-100 and addition of 20microl 1% n-decyl-aldehyde to initiate the luciferase reaction. Light emission was measured in white 96-well plates for 2.5 sec using a Fluoroscan Ascent FL (Thermo Fisher Scientific, Waltham, MA). Binding of FITC-zymosan was quantified by lysis of the cells in 100microl 3% triton X-100. The relative fluorescence was then determined in black 96-well plates using the Fluoroscan Ascent FL. Both BCG- and zymosan binding data were normalized to cell numbers by fluorescently staining an independent set of samples with 5microM CFSE (Molecular Probes) in PBS for 5 min at room temperature. After three washes cells were lysed in 100microl 3% triton X-100 and fluorescence was determined as above.
###end p 58
###begin p 59
###xml 325 326 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All experiments were performed in triplicates, repeated at least three times and calculated as means+/-S.E. Values were expressed as relative light units (R.L.U.) or relative fluorescence units (R.F.U.), respectively, or as x-fold increases compared to controls. Statistical significances were calculated using the Student's t test (*, p<0.05).
###end p 59
###begin title 60
Expression and Functional Screening of a Retroviral cDNA Library
###end title 60
###begin p 61
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Brown1">[24]</xref>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 517 518 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 770 773 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Schafer2">[8]</xref>
###xml 882 889 862 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M.bovis</italic>
###xml 882 893 <span type="species:ncbi:33892">M.bovis BCG</span>
A retroviral cDNA expression library generated from RAW264.7 macrophages cloned into the retroviral vector pFB-Neo (Stratagene) was used for stable transduction of NIH3T3 cells as described [24]. Briefly, 1x106 plat-E cells were transfected per 1microg DNA using FuGENE 6 transfection reagent (Roche Applied Science) according to the manufacturer's instruction and incubated for 24 hr at 37degreesC, followed by another 24 hr incubation at 32degreesC. Retroviral supernatants were harvested and used to transduce 1x105 NIH3T3 cells in the presence of 5microg/ml polybrene (Sigma), which were then selected with 0.4mg/ml G418 (InvivoGen). The screening for cells expressing any mycobacterial-binding receptors was done by fluorescent microscopy as described in detail in [8] on a Zeiss inverted microscope Axiovert 40 CFL after incubation of the stably transfected NIH3T3 cells with M.bovis BCG expressing GFP prepared as described above. Positive cells were ring-isolated using cloning cylinders, expanded in culture for 4-7 days and re-screened until the majority of cells were found to be positive. Viral cDNA inserts were recovered from the genomic DNA of positive cells by conventional PCR using the primers 5'Retro and 3'pFB-Neo (Stratagene) and re-cloned into pFB-Neo for functional testing and sequencing.
###end p 61
###begin title 62
DNA Constructs and Generation of Stable Cell Lines
###end title 62
###begin p 63
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Taylor1">[25]</xref>
The 2.5kb cDNA of SRB1 was derived from the functional screen and subcloned into the retroviral vector pFB-Neo. Subcloning of SIGNR1 in pFB-Neo has been described before [25]. Stable NIH3T3 or R6F cells expressing SRB1 or SIGNR1 were generated by retroviral transduction as described above and grown in the presence of 0.4mg/ml G418 (InvivoGen).
###end p 63
###begin title 64
Western Blotting
###end title 64
###begin p 65
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 411 417 <span type="species:ncbi:9986">Rabbit</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 474 478 <span type="species:ncbi:9925">goat</span>
###xml 484 490 <span type="species:ncbi:9986">rabbit</span>
###xml 495 506 <span type="species:ncbi:3704">horseradish</span>
###xml 711 717 <span type="species:ncbi:9986">rabbit</span>
###xml 723 728 <span type="species:ncbi:10090">mouse</span>
Cells were lysed in Nonidet P-40 buffer (1% Nonidet P-40, 150mM NaCl, 10mM EDTA, 10mM NaN3, 10mM Tris-HCl (pH 8), 2mM Na3VO4, 10mM NaF, and complete EDTA-free protease inhibitors (Roche Applied Sciences) and incubated on ice for 30 min. Nuclei and cell debris were pelleted at 12000g for 20 min at 4degreesC, and supernatants were prepared for SDS-PAGE and Western blotting according to conventional protocols. Rabbit anti-mouse SR-B1 IgG (NB400-104, Novus Biologicals) and goat anti-rabbit IgG horseradish peroxidase conjugate (Jackson Immuno Research Laboratories, Inc.) were used to detect SR-B1 using ECL chemiluminescence substrate (Amersham Biosciences). As a loading control the blots were probed with a rabbit anti-mouse GAPDH monoclonal antibody (Cell Signaling Technology, Inc.).
###end p 65
###begin title 66
Flow Cytometry
###end title 66
###begin p 67
###xml 267 268 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 372 378 <span type="species:ncbi:9986">rabbit</span>
###xml 465 471 <span type="species:ncbi:9986">rabbit</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
###xml 538 541 <span type="species:ncbi:10116">rat</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
###xml 619 624 <span type="species:ncbi:10090">mouse</span>
###xml 630 633 <span type="species:ncbi:10116">rat</span>
###xml 663 669 <span type="species:ncbi:9986">Rabbit</span>
###xml 690 693 <span type="species:ncbi:10116">rat</span>
###xml 811 817 <span type="species:ncbi:9793">donkey</span>
###xml 823 829 <span type="species:ncbi:9986">rabbit</span>
Flow cytometry was performed according to standard protocols at 4degreesC. Briefly, adherent cells were lifted in 4mg/ml lidocaine hydrochloride (Sigma) in PBS supplemented with 10mM EDTA, washed in FACS wash solution (0.5% BSA in PBS) and placed at a density of 1x105 cells in 96-well V-bottom plastic plates. Cells were blocked with 5% BSA in PBS or 5% heat-inactivated rabbit serum, respectively, and examined for the surface expression of SR-B1 or SIGNR1 using rabbit polyclonal anti-mouse SR-B1 IgG (NB400-113, Novus Biologicals) or rat monoclonal anti-mouse ERTR9 IgM (BMA Biomedicals) together with biotinylated mouse anti-rat IgM (Serotec), respectively. Rabbit IgG (Chromopure) or rat IgM (BD PharMingen), respectively, were used as isotype controls. Cells were stained with R-Phycoerythrin-conjugated donkey anti-rabbit IgG (Jackson Immuno Research Laboratories, Inc.) or R-Phycoerythrin-conjugated streptavidin (BD PharMingen), respectively, and fixed with 1% formaldehyde in PBS. The analysis was performed using a FACSCalibur (Becton Dickinson) together with the software CellQuest version 4. For the detection of ligand binding to SR-B1, 10microg/ml DiI-labelled LDL (Molecular Probes) was added to SR-B1 expressing R6F cells in serum-free DMEM for 2 hr at 37degreesC. Cells were then washed three times and lifted with 4mg/ml lidocaine hydrochloride (Sigma) in PBS supplemented with 10mM EDTA. Cells were spun down, resuspended in FACS wash solution containing 1% formaldehyde and analysed for ligand binding by FACS.
###end p 67
###begin title 68
Animals
###end title 68
###begin p 69
###xml 68 74 68 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kri</sup>
###xml 62 74 62 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>tm1Kri</sup></italic>
###xml 81 87 81 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kri</sup>
###xml 75 87 75 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>tm1Kri</sup></italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Rigotti2">[50]</xref>
###xml 423 429 423 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kri</sup>
###xml 417 429 417 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>tm1Kri</sup></italic>
###xml 436 442 436 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kri</sup>
###xml 430 442 430 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>tm1Kri</sup></italic>
###xml 526 532 526 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Kri</sup>
###xml 520 532 520 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>tm1Kri</sup></italic>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 533 540 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scarb1<sup>+</sup></italic>
###xml 675 679 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Rigotti2">[50]</xref>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008448-Trigatti1">[51]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice deficient in SR-B1 and its splice variant SR-B2 (Scarb1tm1Kri/Scarb1tm1Kri) were purchased from the Jackson Laboratory which were originally derived by Rigotti et al.[50]. Animals were maintained under specific pathogen-free conditions in the University of Cape Town animal facility. All work was approved by the Faculty of Health Sciences Animal Ethics Committee, University of Cape Town. As homozygous Scarb1tm1Kri/Scarb1tm1Kri female mice were not fertile, breeding had to be performed with heterozygous Scarb1tm1Kri/Scarb1+ mice. However, the numbers of mutant offspring was significantly less than the expected Mendelian ratio of 1:2:1 as described earlier [50], [51], which significantly limited the number of animals available for experiments. Where indicated, mice were fed either a low cholesterol (LC, 0.15% cholesterol) or a high cholesterol (HC, 1.25% cholesterol) diet (Research Diets, Inc.) two weeks before and throughout the experiment. For these experiments, serum cholesterol levels were measured using the Cholesterol Enzymatic CHOD-PAP kit (KAT Laboratory & Medical (Pty) Ltd.).
###end p 69
###begin title 70
Isolation of Primary Macrophages
###end title 70
###begin p 71
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:9913">calf</span>
###xml 1179 1185 <span type="species:ncbi:10090">murine</span>
Resident or thioglycollate-elicited peritoneal macrophages as well as bone-marrow derived macrophages (BMDmO) were isolated from 8-12 weeks old SR-B1-/- mice or wild type C57BL/6 littermates by standard procedures. To isolate resident alveolar macrophages, lungs were lavaged with 1ml cold PBS (representing the bronchoalveolar lavage (BAL)), followed by repeated washes with 1ml PBS/10mM EDTA. Cells were maintained for 24 hr in RPMI (Invitrogen) with 10% heat-inactivated fetal calf serum (delta bioproducts), 2mM L-glutamine, 100U/ml penicillin and 100microg/ml streptomycin (Sigma) at 37degreesC, except for BMDmO which were cultured in RPMI medium for 5-7 days supplemented with 20% (v/v) L-cell conditioned medium as a source of M-CSF. Binding experiments with these macrophages were performed in the absence of serum (and absence of M-CSF, in the case of BMDmO) as described above. To determine the levels of TNF released into the supernatant, cells were washed after the binding assay in a parallel set of experiments, fresh DMEM containing 10% serum was added, and cells were incubated at 37degreesC. The amount of TNF was measured after 4 hr and 24 hr using the OptEIA murine TNFalpha ELISA kit (BD Biosciences) as described by the manufacturers, and normalized to cell number by CFSE staining. Data represent pooled values from at least 3 independent experiments.
###end p 71
###begin title 72
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis Infections
###end title 72
###begin p 73
###xml 17 43 17 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 368 371 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 17 49 <span type="species:ncbi:83332">Mycobacterium tuberculosis H37Rv</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
Frozen stocks of Mycobacterium tuberculosis H37Rv were thawed, briefly vortexed, and clumping disrupted by aspirating 30 times through a 29-gauge needle. The concentration was adjusted in sterile saline to deliver approximately100 CFU per mouse (low dose infection) or approximately1000 CFU per mouse (high dose infection). Appropriate numbers of 10-14 weeks old SR-B1-/- male and female mice or wild type C57BL/6 littermates were then infected via the aerosol route using an inhalation exposure system (Glas-Col, Terre Haute, IN). In each experiment five mice were sacrificed 24 hr post-infection to confirm the infection dose. Animals were monitored throughout the experiments with regard to body weight and signs of disease. After 2 or 4 months, mice were sacrificed and lungs were removed and weighed. Defined tissue aliquots were homogenized in saline/0.04% Tween-80, and 10-fold serial dilutions were plated in duplicates onto Middlebrook 7H10 agar plates containing 10% OADC (Difco). Plates were incubated at 37degreesC, and colonies were counted after 3 weeks. Data are expressed as CFU per lung.
###end p 73
###begin p 74
Lung homogenates were further analysed to measure the amounts of TNF, IFNgamma, IL10, IL12p70 and IL6 by ELISA with appropriate OptEIA kits (BD Biosciences) as described by the manufacturers.
###end p 74
###begin p 75
###xml 300 303 <span type="species:ncbi:1773">Mtb</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
Lungs were also prepared for histology by fixing the big lobes in 4% phosphate-buffered formalin and then embedding in paraffin. 5 microm-thick sections were stained with haematoxylin and eosin (H&E) for evaluation of pathologic changes. The sizes of inflammatory lesions in four serial sections per Mtb infected mouse lung were determined by automated morphometry using a Nikon inverted microscope eclipse 90i and the software NIS-Elements BR 3.1 (Nikon).
###end p 75
###begin p 76
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
We thank Nasiema Allie, Faried Abbass and Lizette Fick for excellent technical assistance. We further thank Prof Monty Krieger (MIT, Cambridge, MA) for providing access to the SR-B1-/- mice, Dr William Bourn and Prof Anna-Lise Williamson (IIDMM, Cape Town, South Africa) for providing the BCG-GFP strain, as well as Dr Stephen Lawn (IIDMM, Cape Town, South Africa) for providing the BCG-lux strain.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes.
###end article-title 78
###begin article-title 79
###xml 90 116 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages.
###end article-title 79
###begin article-title 80
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 58 84 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.
###end article-title 80
###begin article-title 81
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Mycobacterium tuberculosis infection in complement receptor 3-deficient mice.
###end article-title 81
###begin article-title 82
###xml 25 51 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
###end article-title 82
###begin article-title 83
###xml 121 147 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.
###end article-title 83
###begin article-title 84
###xml 153 172 <span type="species:ncbi:1764">Mycobacterium avium</span>
Complex encounters at the macrophage-mycobacterium interface: studies on the role of the mannose receptor and CD14 in experimental infection models with Mycobacterium avium.
###end article-title 84
###begin article-title 85
Generation of retroviral macrophage cDNA expression libraries and functional screening for surface receptors.
###end article-title 85
###begin article-title 86
The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation.
###end article-title 86
###begin article-title 87
###xml 30 56 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Is adipose tissue a place for Mycobacterium tuberculosis persistence?
###end article-title 87
###begin article-title 88
###xml 111 137 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.
###end article-title 88
###begin article-title 89
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.
###end article-title 89
###begin article-title 90
The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders.
###end article-title 90
###begin article-title 91
Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids.
###end article-title 91
###begin article-title 92
High density lipoprotein receptors, binding proteins, and ligands.
###end article-title 92
###begin article-title 93
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
###end article-title 93
###begin article-title 94
The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids.
###end article-title 94
###begin article-title 95
CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins.
###end article-title 95
###begin article-title 96
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection.
###end article-title 96
###begin article-title 97
CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells.
###end article-title 97
###begin article-title 98
###xml 37 54 <span type="species:ncbi:11103">hepatitis C virus</span>
High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
###end article-title 98
###begin article-title 99
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 105 122 <span type="species:ncbi:11103">hepatitis C virus</span>
High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.
###end article-title 99
###begin article-title 100
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.
###end article-title 100
###begin article-title 101
Immune recognition. A new receptor for beta-glucans.
###end article-title 101
###begin article-title 102
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages.
###end article-title 102
###begin article-title 103
Essential role for cholesterol in entry of mycobacteria into macrophages.
###end article-title 103
###begin article-title 104
###xml 38 64 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
###end article-title 104
###begin article-title 105
Hypercholesterolemia impairs immunity to tuberculosis.
###end article-title 105
###begin article-title 106
Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution.
###end article-title 106
###begin article-title 107
Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells.
###end article-title 107
###begin article-title 108
###xml 50 76 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
CD43 is required for optimal growth inhibition of Mycobacterium tuberculosis in macrophages and in mice.
###end article-title 108
###begin article-title 109
###xml 57 69 <span type="species:ncbi:100235">actinomycete</span>
###xml 92 118 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.
###end article-title 109
###begin article-title 110
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis and the macrophage: maintaining a balance.
###end article-title 110
###begin article-title 111
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors.
###end article-title 111
###begin article-title 112
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals.
###end article-title 112
###begin article-title 113
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria.
###end article-title 113
###begin article-title 114
Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively.
###end article-title 114
###begin article-title 115
Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.
###end article-title 115
###begin article-title 116
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 115 134 <span type="species:ncbi:1764">Mycobacterium avium</span>
Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
###end article-title 116
###begin article-title 117
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 47 73 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
###end article-title 117
###begin article-title 118
###xml 63 89 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.
###end article-title 118
###begin article-title 119
###xml 48 74 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.
###end article-title 119
###begin article-title 120
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions.
###end article-title 120
###begin article-title 121
###xml 30 56 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
###end article-title 121
###begin article-title 122
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 62 88 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination.
###end article-title 122
###begin article-title 123
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment.
###end article-title 123
###begin article-title 124
###xml 32 35 <span type="species:ncbi:10116">rat</span>
###xml 83 106 <span type="species:ncbi:11786">murine leukemia viruses</span>
Morphological transformation of rat embryo cells induced by diethylnitrosamine and murine leukemia viruses.
###end article-title 124
###begin article-title 125
Plat-E: an efficient and stable system for transient packaging of retroviruses.
###end article-title 125
###begin article-title 126
Assessment of immunity to mycobacterial infection with luciferase reporter constructs.
###end article-title 126
###begin article-title 127
###xml 27 33 <span type="species:ncbi:10090">murine</span>
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.
###end article-title 127
###begin article-title 128
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.
###end article-title 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 129
###begin p 130
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG), Germany, to GS (grant SCHA 1470/1-1), the Claude Leon Foundation, South Africa, to GS and RG, the National Research Foundation (NRF), South Africa, to FB, the South African Research Chair Initiative of the Department of Science and Technology (DST) to FB, and the Wellcome Trust to GDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 130

